Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Human Chorionic Gonadotropin Market Size Likely To Evolve From 2025 Through 2034?
The human chorionic gonadotropin market has experienced substantial expansion recently. Projections indicate a rise from $0.95 billion in 2024 to $1.02 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.4%. This historical growth is attributable to several factors, including the increasing incidence of hypogonadism among the elderly, enhanced understanding of HCG among both medical professionals and individuals, the growing appeal of fertility tourism, the expanding elderly demographic, and better access to affordable and improved healthcare services.
The human chorionic gonadotropin market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach “$1.41 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.2%. This projected growth during the forecast period stems from factors such as the increasing incidence of infertility, the surging prevalence of polycystic ovary syndrome, the rise in female infertility, and the growing application of HCG in veterinary medicine. Key trends expected within this period encompass advancements in pregnancy detection, the development of innovative drug formulations, greater technological integration, a strong focus on research and development, and continuous product innovation.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp
Which Factors And Drivers Are Influencing The Human Chorionic Gonadotropin Market In 2025?
The human chorionic gonadotropin market is anticipated to expand, propelled by a rising prevalence of infertility. This condition is defined as the failure to achieve pregnancy following a minimum of one year of regular, unprotected sexual activity. The proportion of individuals and couples facing challenges in conception is on the rise, influenced by various factors including later parenthood, evolving lifestyles, exposure to environmental elements, and underlying health issues. Human chorionic gonadotropin (hCG) plays a crucial role in infertility therapies, where it promotes ovulation in females and aids testosterone synthesis in males, thereby assisting in egg release and enhancing reproductive success. As an illustration, figures from April 2023, released by the World Health Organization, a Switzerland-based intergovernmental organization, indicated that approximately 17.5% of adults globally, or about one in every six individuals, were impacted by infertility. This underscores the urgent necessity to enhance the availability of affordable, excellent fertility treatment for those requiring it. Consequently, the escalating incidence of infertility is fueling the expansion of the human chorionic gonadotropin market.
What Are The Primary Types Of Segments Analyzed In The Human Chorionic Gonadotropin Market?
The human chorionic gonadotropinmarket covered in this report is segmented –
1) By Technology: Natural Source Extraction; Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment; Oligospermic Treatment; Male Hypogonadism; Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Fertility Clinics; Research Institutions; Other End Users
Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine; Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg; Recombinant Hcg For Therapeutic Use; Recombinant Hcg For Diagnostic Applications
Which Competitive Trends Are Defining The Human Chorionic Gonadotropin Market Structure?
Major companies operating in the human chorionic gonadotropin market are concentrating on developing innovative products, such as pregnancy detection kits, to improve diagnostic accuracy, enhance patient outcomes, and expand their market reach. These kits are tools designed to confirm pregnancy by detecting human chorionic gonadotropin (hCG) in an individual’s body. For instance, in June 2022, Proov, a US-based medical equipment manufacturing company, launched new hCG tests specifically for early pregnancy detection, enabling women to verify pregnancy up to six days before their expected period. These tests function by identifying the presence of human chorionic gonadotropin (hCG) in the urine, offering high accuracy with a reliability rate exceeding 99. This innovation seeks to provide women with a dependable and accessible method to monitor their pregnancy status earlier than traditional tests, empowering them to make informed decisions regarding their reproductive health.
Who Are The Major Companies Operating In The Human Chorionic Gonadotropin Market?
Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report
How Do Regional Market Performances Compare Within The Human Chorionic Gonadotropin Industry?
North America was the largest region in the human chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Human Chorionic Gonadotropin Market Report:
https://www.thebusinessresearchcompany.com/customise?id=18638&type=smp
Browse Through More Reports Similar to the Global Human Chorionic Gonadotropin Market 2025, By The Business Research Company
Mineral And Bone Disorder Treatment Global Market Report 2025
Acute Spinal Cord Injury Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report
Cleanroom Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cleanroom-technology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model